Hydrophobic Interaction Chromatography Market Research Report Information By Product and Service (Resins, Columns, Services, Others), Sample Type (Monoclonal Antibodies, Vaccines, Others), End-User (Research & Academic Institutes) - Forecast Till 2032

Hydrophobic Interaction Chromatography Market Overview 

The Hydrophobic Interaction Chromatography market is anticipated to reach USD 0.44 Billion by 2032 at 7.7% CAGR during the forecast period 2023-2032. Hydrophobic Interaction Chromatography (HIC) is a technology for separating compounds based on their hydrophobicity properties. Hydrophobic interaction chromatography (HIC) has emerged as a potent technology for purifying biological substances on an industrial and laboratory scale in recent years. HIC is also commonly utilized in biopharmaceutical businesses for protein purification and separation. The market is being propelled forward by rising demand for monoclonal antibodies and rising research & development investment in biopharmaceuticals. In the hydrophobic interaction chromatography market, Europe is expected to retain the second-largest share. The European market is likely to be driven by increased money supplied by the government and commercial organizations for research and development. The need for mAbs has risen dramatically in the last decade, not only in oncology but also in other therapeutic areas such as Alzheimer's disease, autoimmune illnesses, and inflammatory disorders. In recent years, these therapeutic domains have gained popularity, as a result of which practically all major pharmaceutical companies have invested in therapeutic antibody research and development. Impurities and aggregates are removed from mAbs using a variety of chromatography resins, including hydrophobic interaction chromatography resins. Hydrophobic interaction chromatography is used in drug discovery applications to capture and polish target proteins during the purification process.

Segmentation

The hydrophobic interaction chromatography market has been segmented into product and service, sample type, and end-user.

The market, on the basis of products and services, has been segmented into products such as resins, columns, HIC columns, buffers, and other products and services. The resins segment has been segmented into bead-based resins and membrane-based resins. The column segment has been further segmented into empty columns and pre-packed columns.

HIC columns on the basis of material are further segmented into stainless steel columns and glass and plastic columns.

The market, by sample type, has been segmented into monoclonal antibodies, vaccines, and others.

The market, by end-user, has been segmented into pharmaceutical and biopharmaceutical companies, contract research organizations and contract manufacturing organizations, research and academic institutes, and others.

Geographically, the hydrophobic interaction chromatography market has been segmented into the Americas, Europe, Asia-Pacific, and the Middle East and Africa. The American hydrophobic interaction chromatography market is further segmented into North America and South America. North America is further classified as the US and Canada.

The European hydrophobic interaction chromatography market is segmented into Western Europe and Eastern Europe. Western Europe is further classified as Germany, France, the UK, Italy, Spain, and the Rest of Western Europe.

The Asia-Pacific hydrophobic interaction chromatography market is segmented into Japan, China, India, the Republic of Korea, Australia, and the Rest of Asia-Pacific.

The Middle Eastern and African hydrophobic interaction chromatography market is segmented into the Middle East and Africa.

Regional Market Summary

Hydrophobic Interaction Chromatography Market, by Region Market Share, 2017 (%)

Source: White Papers, Annual Reports, Company Presentations

The hydrophobic interaction chromatography market consists of four regions, namely, the Americas, Europe, Asia-Pacific, and the Middle East and Africa. The Americas is expected to dominate the hydrophobic interaction chromatography market owing to the presence of government and public funding for protein-based research projects, rising automation of purification equipment, and growing demand for protein-based biologics. Additionally, the increasing research and development expenditure is expected to contribute to the market growth in the region. According to the UNESCO Institutes for Statistics, in the US, the research & development expenditure was 2.79% of the GDP (Gross Domestic Product) in 2015.

Europe is anticipated to hold the second largest position in the hydrophobic interaction chromatography market. It is expected that the increasing funding provided by the government and private organizations towards research and development is anticipated to drive the European market.

The Asia-Pacific hydrophobic interaction chromatography market consists of countries, namely, China, Japan, the Republic of Korea, India, Australia, and the Rest of Asia-Pacific. Asia-Pacific is expected to be the fastest growing region in the hydrophobic interaction chromatography market. Major factors such as a growing number of contract research organizations, developing healthcare infrastructure,  increasing research and development activities in the biotechnology sector and increasing healthcare expenditure influence the market in this region.

The Middle East and Africa holds the least share in the hydrophobic interaction chromatography market due to the presence of stringent government policies and poor economies. However, growing awareness among the population and high investments by private market players in this region can boost the market growth.Recent Development

According to the European Federation of Pharmaceutical Industries and Associations, the pharmaceutical sector spent EUR 35000 million on research and development in 2016. Furthermore, the growing number of contract research and manufacturing businesses is likely to boost the market growth. According to the UNESCO Institutes for Statistics, research and development expenditure in the United States was 2.79 percent of GDP in 2015. Additionally, rising R&D spending is likely to add to regional market growth. The global market for hydrophobic interaction chromatography is fragmented and competitive for this company. To enhance its market share, this player is focused on product developments, new product launches, and geographical expansions.

Key Players

Bio-Rad Laboratories, Sartorius AG, Thermo Fisher Scientific, GE Healthcare, Tosoh Corporation, Waters Corporation, Geno Technology, Sepax Technologies, JNC Corporation, Agilent Technologies, Merck KGaA, Mitsubishi Chemical Corporation, Danaher Corporation, and Avantor Performance Materials are some of the key players in the global hydrophobic interaction chromatography market.

Hydrophobic Interaction Chromatography Market, by Product and Service

• Products


• Resins


• Bead-Based Resins


• Membrane-Based Resins


• Columns


• Empty Columns


• Prepacked Columns


• HIC Columns, By Materials


• Stainless Steel Columns


• Glass & Plastic Columns


• Buffers


• Other Products


• Services

Hydrophobic Interaction Chromatography Market, by Sample Type

• Monoclonal Antibodies


• Vaccines


• Others

Hydrophobic Interaction Chromatography Market, by End-User

• Pharmaceutical & Biopharmaceutical Companies


• Contract Research Organizations & Contract Manufacturing Organizations


• Research & Academic Institutes


• Others

Hydrophobic Interaction Chromatography Market, by Region

• Americas
  
  
  
  • North America
  
  
  • US
  
  
  • Canada
  
  
  • South America
  
  
  
  


• Europe
  
  
  
  • Western Europe
    
    
    
    • Germany
    
    
    • France
    
    
    • Italy
    
    
    • Spain
    
    
    • UK
    
    
    • Rest of Western Europe
    
    
    
    
  
  
  • Eastern Europe
  
  
  
  


• Asia-Pacific
  
  
  
  • Japan
  
  
  • China
  
  
  • India
  
  
  • Australia
  
  
  • Republic of Korea
  
  
  • Rest of Asia-Pacific
  
  
  
  


• Middle East & Africa
  
  
  
  • Middle East
  
  
  • Africa
  
  
  
  

Report Scope:

 

Report Attribute/Metric	Details
Market Size	0.44 Billion
CAGR	7.7% (2023-2032)
Base Year	2021
Forecast Period	2023-2032
Historical Data	2018
Forecast Units	Value (USD Billion)
Report Coverage	Revenue Forecast, Competitive Landscape, Growth Factors, and Trends
Segments Covered	Product and Service, Sample Type, and End-user
Geographies Covered	North America, Europe, Asia-Pacific, and Rest of the World (RoW)
Key Vendors	Bio-Rad Laboratories, Sartorius AG, Thermo Fisher Scientific, GE Healthcare, Tosoh Corporation, Waters Corporation, Geno Technology, Sepax Technologies, JNC Corporation, Agilent Technologies, Merck KGaA, Mitsubishi Chemical Corporation, Danaher Corporation, and Avantor Performance Materials
Key Market Opportunities	Increasing number of contract research organizations and contract manufacturing organizations
Key Market Drivers	·  Rising demand for monoclonal antibodies ·  Increasing research and development expenditure in biopharmaceuticals

 

Frequently Asked Questions (FAQ) :